Identifying Causal Rare Variants of Disease Through Family-based Analysis of Genetics Analysis Workshop 17 Data Set by Yip, Wai-Ki et al.
 
Identifying Causal Rare Variants of Disease Through Family-
based Analysis of Genetics Analysis Workshop 17 Data Set
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Yip, Wai-Ki, Gourab De, Benjamin A Raby, and Nan Laird.
2011. Identifying causal rare variants of disease through family-
based analysis of Genetics Analysis Workshop 17 data set. BMC
Proceedings 5(Suppl 9): S21.
Published Version doi:10.1186/1753-6561-5-S9-S21
Accessed February 19, 2015 9:30:49 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:8641842
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAAPROCEEDINGS Open Access
Identifying causal rare variants of disease through
family-based analysis of Genetics Analysis
Workshop 17 data set
Wai-Ki Yip
1*†, Gourab De
1†, Benjamin A Raby
2, Nan Laird
1†
From Genetic Analysis Workshop 17
Boston, MA, USA. 13-16 October 2010
Abstract
Linkage- and association-based methods have been proposed for mapping disease-causing rare variants. Based on
the family information provided in the Genetic Analysis Workshop 17 data set, we formulate a two-pronged
approach that combines both methods. Using the identity-by-descent information provided for eight extended
pedigrees (n = 697) and the simulated quantitative trait Q1, we explore various traditional nonparametric linkage
analysis methods; the best result is obtained by assuming between-family heterogeneity and applying the
Haseman-Elston regression to each pedigree separately. We discover strong signals from two genes in two
different families and weaker signals for a third gene from two other families. As an exploratory approach, we
apply an association test based on a modified family-based association test statistic to all rare variants (frequency <
1% or < 3%) designated as causal for Q1. Family-based association tests correctly identified causal single-nucleotide
polymorphisms for four genes (KDR, VEGFA, VEGFC, and FLT1). Our results suggest that both linkage and association
tests with families show promise for identifying rare variants.
Background
In contrast to the common variant/common disease
hypothesis that dominated the era of linkage-disequili-
brium-based genome-wide association studies (GWAS),
there is increasing awareness that rare variants of modest
to large individual effect contribute to disease liability
and may explain a substantial proportion of the so-called
missing heritability of common traits. There is therefore
great interest in developing statistical methods to detect
rare causal variants. Rare variant analysis is complicated
by several unique challenges related to sequencing-based
uncertainties in variant calling, the large search space of
rare variants, and the inherently low carrier rate frequen-
cies of these variants. It has been theorized that both
linkage and family-based analysis work well in analyzing
rare variants [1,2]. Combining both approaches may pro-
vide a powerful strategy for identifying rare variants.
Methods
The Genetic Analysis Workshop 17 (GAW17) data set
was developed to model a real-world rare variant screen
using data generated from a mini-exome scan [3]. The
genotype data correspond to 24,487 variants (in 3,205
genes) derived from low-coverage sequence data provided
from the 1000 Genomes Project. In our analysis, we use
the simulated family-based sample of eight three-genera-
tion pedigrees (697 individuals). The founders of these
pedigrees are a random sample of 202 individuals selected
from the population-based sample. As a result, only four
of the nine causal genes have low-frequency causal single-
nucleotide polymorphisms (SNPs) in the family data. In
our linkage analysis and initial family-based association
test (FBAT) analysis, we average the 200 replications of
the Q1 phenotype to maximize power. Detailed informa-
tion about the pedigrees is shown in Table 1.
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Our initial goal is to evaluate a variety of linkage-based
approaches using the within-family identity-by-descent
(IBD) information provided. In the absence of knowledge
regarding the disease model, we restricted our evaluation
to nonparametric methods so as to maximize power [4].
We evaluated several approaches that consider either all
sib pairs (SPs) or only affected sib pairs (ASPs), including
goodness-of-fit, mean, and trend test using ASPs and the
Haseman-Elston and modified Haseman-Elston regres-
sions using all SPs [4-7]. We also used the Haseman-
Elston regression with Q1. Because this proved to be the
most powerful, we restrict our reporting to this approach.
Family-based association test
The resolution of linkage analysis is limited by the num-
ber of informative meioses within each pedigree (a func-
tion of pedigree structure and randomness). We
therefore consider family-based association methods to
facilitate fine mapping of linked regions. The association
test is based on a modified FBAT [8] statistic as follows:
S u p p o s ew eh a v ei =1 ,…, N independent trios and M
rare variants in a given gene. We apply the test to mar-
kers using a defined rare variant allele frequency thresh-
old (<1% and 3% are illustrated). The cutoff is arbitrary
and deserves further exploration. The test statistic has
the following numerators:
WW T X E X P iii i i ==−− ⎡ ⎣ ⎤ ⎦ ∑∑ () () , m (1)
where Ti is the trait, Xi is the observed number of rare
variant alleles among the offspring for the ith family, μ
is the trait offset (typically the mean for measured
traits), and Pi is the parental genotype corresponding to
the ith family. The numerator is the sum of individual
numerators of each of the FBAT statistics for all M
SNPs. It represents the contributions for all families
over all variants in a given gene to the new FBAT statis-
tics. The test statistic W/[Var(W)]
1/2 is a Z-statistic that
c a nb eu s e dt ot e s ta g a i n s tao n e - s i d e do rt w o - s i d e d
alternative.
The variance of W has a complicated expression. Even
if we assume that the nuclear families within a pedigree
are independent, estimating the covariance structure
between the SNPs for each family is difficult because of
the presence of linkage disequilibrium between variants.
For the purpose of this project, we use the empirical
variance as the denominator, which gives:
Var( ) . WW i =∑
2 (2)
Instead of trios, we can extend the numerator by sum-
ming contributions over all nuclear families in all pedi-
grees:
WT X E X P lik lik lik ik
l i k
=− − () ⎡
⎣
⎤
⎦ ∑ ∑ ∑ () , m (3)
where the summand corresponds to the lth offspring
of the ith nuclear family in the kth pedigree. We can
compute the empirical variance in two different ways,
by treating either the pedigrees:
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or the nuclear families:
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2
(5)
as independent units, where the term in braces in
expression (4) or (5) is the contribution of the pedigree
or the nuclear family. The choice of assumption has
important implications for test performance. Assuming
that nuclear families are independent gives a biased esti-
mate of the variance if indeed phenotypic correlation
exists between nuclear families within a pedigree. Alter-
natively, assuming that pedigrees are independent gives a
conservative estimate of the variance when only a small
number of pedigrees are studied, as in the GAW17 family
data. This test can also be extended to nuclear families
Table 1 Pedigree information based on the combined sample
Pedigree number Number of nuclear families Number of affected sibs Total number of sib pairs Number of affected sib pairs
02 3 2 2 8 6 5
1 29 26 100 8
22 6 2 9 9 0 4
32 0 1 9 7 4 1
42 0 1 8 7 3 2
52 0 2 0 7 3 7
6 36 48 128 34
72 0 1 8 7 3 1
Total 194 200 697 62
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tistic for transmission instead of parental genotype.
Results
Comparison of linkage-based approaches
We observe striking differences in the performance of the
various linkage-based approaches evaluated. Any linkage
method that aggregated results across pedigrees failed to
identify any of the causal genes among the top candidates.
In contrast, when genetic heterogeneity was considered by
performing pedigree-stratified analysis, some of the causal
genes were identified. The results are summarized in
Table 2. KDR (p = 2.0 × 10
−8) is the top gene and is most
significant in one pedigree; VEGFA (p =1 . 4×1 0
−5)i s
among the top significant genes in another pedigree; and
FLT1 (p = 5.4 × 10
−3 and 1.0 × 10
−3) shows up as the top
gene in two other pedigrees, but the signal seems to be
significantly weaker.
Fine mapping result
To assess the performance of our modified FBAT statis-
tic, we first screened all variants with a frequency less
than 1% for association using a univariate application of
the standard FBAT statistic (considering individual var-
iants separately). We found that, with the exception of
one disease-causing variant (C4S1884), all the variants
demonstrated trends of association (at a =0 . 0 5 ) ,
although none reached significance after adjustment for
multiple tests. We next applied our modified FBAT,
performing gene-based tests of all rare variants with fre-
quencies less than 1% or less than 3%. The p-values cor-
responding to the true causal genes are summarized in
Table 3. Of the four genes with causal rare variants in the
family data, we detected association (p < 0.01) for three
genes (VEGFA, VEGFC,a n dFLT1), and for the fourth
gene (KDR), significance was achieved using the higher
frequency. Using pedigrees as independent units instead
of nuclear families yielded nonsignificant results; given
the small number of pedigrees, this was expected.
To estimate the FBAT statistic’s true- and false-posi-
tive rates, we ran our method on the 200 individual phe-
notype replicates and reported the proportion of times a
gene was declared significant (at p < 0.01). As can been
seen in Table 4, the FBAT has high power to detect
association for three of the four polymorphic causal
genes: power approaches 1 for VEGFA and VEGFC,
regardless of allele frequency cutoff, whereas power var-
ies by allele frequency cutoff for FLT1. Power is poor
for KDR, regardless of cutoff. Among genes that were
modeled as disease causing but for which random sam-
pling resulted in the absence of polymorphic rare var-
iants in our data sets, the false-positive rates are low.
Two related genes, HIF1A and HIF3A,h a v ef a l s e - p o s i -
tive rates of 0, and the other three genes have rates no
higher than 0.02, suggesting high test specificity (not
shown). However, a more comprehensive assessment of
all genes reveals a substantially higher false-positive rate.
Figure 1 graphs the detection rates for all genes on
Table 2 Top candidate genes from separate pedigrees
Pedigree 1 p-value Pedigree 3 p-value Pedigree 4 p-value Pedigree 5 p-value
GPR115 0.000004 KDR 0.00000002 EPHA6 0.0052 PIBF1 0.0003
C6orf130 0.000013 KIT 0.00000002 GPR128 0.0052 CCNA1 0.0009
GUCA1B 0.000013 LNX1 0.00000002 OR5K1 0.0052 CYSLTR2 0.0009
KIAA0240 0.000013 PDGFRA 0.00000002 OR5K2 0.0052 DGKH 0.0009
MEA1 0.000013 SGCB 0.00000002 OR5K3 0.0052 DNAJC15 0.0009
PPP2R5D 0.000013 SPATA18 0.00000002 OR5K4 0.0052 ELF1 0.0009
PRPH2 0.000013 PPAT 0.00000045 ST3GAL6 0.0052 FNDC3A 0.0009
PTK7 0.000013 SPINK2 0.00000045 B3GALTL 0.0054 FREM2 0.0009
RGL2 0.000013 GUF1 0.00005598 BRCA2 0.0054 HTR2A 0.0009
SLC26A8 0.000013 NFXL1 0.00005598 FLT1 0.0054 NUFIP1 0.0009
TAF11 0.000013 CHRNA9 0.00047549 LOC650794 0.0054 P2RY5 0.0009
TBCC 0.000013 NSUN7 0.00047549 SGCG 0.0054 RB1 0.0009
TFEB 0.000013 RHOH 0.00047549 TNFRSF19 0.0054 RCBTB2 0.0009
ZNF76 0.000013 LZTR1 0.00167619 ZMYM2 0.0054 TRPC4 0.0009
NFKBIE 0.000014 SCARF2 0.00167619 ZMYM5 0.0054 FLT1 0.0010
RUNX2 0.000014 SDF2L1 0.00167619 NFKBIZ 0.0092 STARD13 0.0011
SUPT3H 0.000014 TOP3B 0.00167619 STARD13 0.0208 B3GALTL 0.0013
VEGFA 0.000014 JMJD2C 0.00242110 ATP10A 0.0213 BRCA2 0.0013
HFE 0.000019 PTPRD 0.00242110 ADCY5 0.0229 LOC650794 0.0015
HIST1H2AA 0.000019 KIAA1432 0.00303729 ADPRH 0.0229 SGCG 0.0015
Linkage analysis results of top candidate genes by regressing the square of the difference of Q1 against IBD for all sib pairs in a pedigree.
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that seem to have high rates of detection despite not
being associated with the trait. Most notable are
PCDHGA2 (rate = 0.245), PSMB8 (rate = 0.475), and
TRPC4 (rate = 0.205). The high false-positive rate for
KIT can be explained by its close proximity to KDR.
Discussion
Rare variants are likely to be private to one or a limited
number of families. As a consequence, it is likely that the
genetic liability conferred by rare variants will exhibit pro-
nounced genetic heterogeneity, with different individual
contributions from numerous variants. It is well recog-
nized that model misspecification, including failure to con-
sider allelic heterogeneity, can severely limit disease-gene
mapping efforts. It therefore follows that gene-mapping
efforts that focus on rare variants accommodate this rea-
lity. In our study, aggregating linkage statistics across all
pedigrees yielded negative results, whereas modeling link-
age within individual pedigrees performed well. So linkage
analysis shows some promise in analyzing rare variants
given sufficiently large pedigrees.
The modified FBAT is promising. It correctly identifies
causal genes that contain polymorphic SNPs in the family
sample. However, we found that there were considerable
false positives; many factors could be responsible for the
high false-positive rates, for example, failure to adjust for
multiple testing, linkage disequilibrium between causal
and noncausal SNPs, incorrect variance estimation, lack
of normality resulting from the restriction to rare var-
iants, and the method used to simulate the replications.
With regard to variance estimation, there are only 8
pedigrees and 194 nuclear families, so differences in the
two approaches to computing the variance are to be
expected. In study designs often seen in actual samples,
these differences may not be so important, but clearly, bet-
ter approaches are needed. Some limited examination of
the sensitivity of the false-positive rate suggests that the
use of only rare variants does not have a major impact.
Furthermore, the simulation structure of the family-based
sample makes it difficult to evaluate performance of any
family-based methods. First, many of the true causal SNPs
are not polymorphic in the family-based sample, making it
impossible for both linkage and association analyses to
identify the causal genes with those variants. Second, for
the proposed family-based methods the random variable is
the transmission of genotype. Hence the simulated repli-
cates of phenotypes cannot be used to appropriately evalu-
ate power or validity of such methods.
Further research should investigate possible approaches
to extend the proposed association test using variable
thresholds for identifying rare variants and using available
pathway information. Another issue that can be addressed
in future research is the assumption that all rare variants
act in the same direction, affecting the disease risk; poten-
tial ways to address the violation of such an assumption in
the context of our method should be tested.
Conclusions
Linkage, stratified by pedigree, provides a promising
method for identifying rare variants, provided that pedi-
grees are large. The modified FBAT approach also sug-
gests that it is a promising approach, but the false-positive
rates need to be addressed. Although not attempted here,
Table 4 True-positive rates corresponding to the true
causal genes using Q1 as phenotype (estimated from the
200 replications provided in the GAW17 data set)
Chromosome Gene 1% cutoff 3% cutoff
4 KDR 0.085 0.035
4 VEGFC 0.995 1
6 VEGFA 0.995 0.990
13 FLT1 0.075 0.775
Table 3 P-values corresponding to the true causal genes using Q1 as phenotype
Chromosome Gene 1% cutoff 3% cutoff
Nuclear families Pedigrees Nuclear families Pedigrees
1 ARNT 0.441 0.301 0.450 0.406
1 ELAVL4 0.447 0.347 0.952 0.948
4 KDR
a 0.03 0.09 0.229 0.092
4 VEGFC
a 0.009 0.317 0.009 0.317
5 FLT4 0.314 0.299 0.319 0.304
6 VEGFA
a 0.0002 0.122 0.002 0.156
13 FLT1
a 0.076 0.128 0.0003 0.024
14 HIF1A NA NA 0.317 0.317
19 HIF3A 0.508 0.466 0.638 0.609
a Gene that has polymorphic causal SNPs. The other five causal genes (not marked by superscript a) cannot be identified in our method because there were no
causal SNPs corresponding to those genes in the sample.
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approaches, using linkage to screen genes or regions and
then using the FBAT for testing selected regions. Given
the scale of large-scale sequencing, this approach not only
m a yb em o r ep o w e r f u lb u tm a ya l s op r o v i d es u b s t a n t i a l
cost savings. Finally, methods for evaluating power and
type I error for linkage and transmission testing need to
be designed differently to provide valid estimates for those
tests.
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Figure 1 Detection rates from modified FBAT for all genes on chromosomes 4, 5, 6, and 13. Each bar in the graphs represents the
percentage of times that the gene was significant (p < 0.05) in the 200 replicates. True-positive disease genes are labeled. Of note, the KIT locus
on chromosome 4, frequently detected as a false positive, is in close proximity (394 kb) to the disease-causing KDR locus.
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